 |
|
|
|
|
|
|
| Article 1 to 10 out of 18 concerning AstraZeneca PLC
|
-
ChemBridge Corporation Enters Into New Discovery Chemistry Strategic Alliance With AstraZeneca
(26 Sep 2008)
ChemBridge Corporation announced new multi-year research collaboration in discovery chemistry with AstraZeneca. This new alliance follows the previous collaboration between ChemBridge and AstraZeneca that was established in 2006 and successfully ...
-
Thermo Fisher Scientific named a Microsoft Pharmaceutical and Life Sciences Innovation Award winner for Informatics Solutions
(10 Jul 2008)
Thermo Scientific Nautilus LIMS(TM) recognized for driving better business decisions at AstraZeneca
Thermo Fisher Scientific announced that it is the winner of a Microsoft Corporation 2008 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation category. The award honors best-in-class companies that have made the ...
-
Tagging-detagging for purification of radiotracers
(10 Jun 2008)
Veronique Gouverneur and colleagues from the University of Oxford and AstraZeneca, Cheshire, have developed a novel tagging-detagging strategy. This could be extremely useful for the purification of known and novel 18F-radiotracers for Positron ...
-
BASF wins IChemE Award 2007
(30 Oct 2007)
Prize for cyclododecanone production process
BASF received the ""AstraZeneca Award for Excellence in Green Chemistry and Engineering", one of eight "IChemE Awards 2007", for its novel process for producing cyclododecanone (CDon).This new process developed by BASF researchers consists of three ...
-
AstraZeneca to acquire MedImmune for $15.2 billion
(25 Apr 2007)
AstraZeneca PLC announced that it has entered into a definitive agreement to acquire MedImmune, Inc. in an all-cash transaction. Under the terms of the agreement, which has unanimous MedImmune Board support, AstraZeneca will acquire all of the fully ...
-
AstraZeneca is building a pharmaceutical solid forms production facility near Cairo
(20 Feb 2007)
AstraZeneca is building a pharmaceutical solid forms production facility in Sixth of October City (Madinat Sittah Uktubar) near Cairo. The new facility will have 7,000mē of floor space and will employ up to 300 new employees when completed towards ...
-
Out of REACH
(21 Nov 2006)
New legislation threatens medicines
Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ ...
-
AstraZeneca Announces $100 Million R&D Investment in China
(30 May 2006)
New Innovation Centre to Focus Initially on Oncology Research
AstraZeneca intents to invest $100 million in R&D in China over the next three years, focusing on the benefit and value of innovative medicines for Chinese patients. The prime focus of this programme will be the establishment of the AstraZeneca ...
-
AstraZeneca commences patent infringement litigation against IVAX
(13 Mar 2006)
AstraZeneca announced that it has filed a lawsuit in the United States District Court for the District of New Jersey against IVAX Corporation, IVAX Pharmaceuticals, Inc. and Zenith Laboratories, Inc. (collectively "IVAX"), and IVAX's parent, Teva ...
-
Astra Zeneca opens multi-million dollar research facility in India
(02 Jun 2003)
Focus on new treatments for tuberculosis
AstraZeneca today opened a new multi-million dollar research facility in Bangalore, India, which will focus principally on finding new treatments for tuberculosis (TB), a disease which is diagnosed in about two million people every year in India and ...
|
|
|
|
|
Top